Key facts
- Heuristik’s last known valuation is $4.0M (Jan 2025).
- It has raised $1.1M; the latest was Later Stage VC in Dec 2025.
- Notable investors include MassChallenge, University of Oxford, Massachusetts Institute of Technology, Caelestinus, Neotec Capital Riesgo — 21 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 21 names
- ·Watchlist + deal alerts for Heuristik
- ·The full record, as it builds
Funding rounds
No funding rounds for Heuristik are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Heuristik
Developer of a patient identification and management technology designed to increase the efficiency of patient identification. The company's technology combines biometrics and artificial intelligence that identify fingerprints and patient information and management of medical records, enabling healthcare entities to reduce costs, streamline patient identification and management processes, favor interoperability, reduce fraud, and improve the patient experience.
- Sector
- Healthcare
- HQ
- Getxo, Spain
- Founded
- 2019
- Employees
- 13
- Website
- heuristik.tech/
- Ownership
- Privately Held (backing)
Heuristik doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Heuristik shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Heuristik in its N-PORT filings yet. We sweep new filings monthly.